Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity

被引:165
作者
Zajonc, DM
Maricic, I
Wu, D
Halder, R
Roy, K
Wong, CH
Kumar, V
Wilson, IA
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[4] Torrey Pines Inst Mol Sci, San Diego, CA 92121 USA
关键词
D O I
10.1084/jem.20051625
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sulfatide derived from the myelin stimulates a distinct population of CD1d- restricted natural killer T ( NKT) cells. Cis- tetracosenoyl sulfatide is one of the immunodominant species in myelin as identified by proliferation, cytokine secretion, and CD1d tetramer staining. The crystal structure of mouse CD1d in complex with cis- tetracosenoyl sulfatide at 1.9 angstrom resolution reveals that the longer cis- tetracosenoyl fatty acid chain fully occupies the A ' pocket of the CD1d binding groove, whereas the sphingosine chain fills up the F ' pocket. A precise hydrogen bond network in the center of the binding groove orients and positions the ceramide backbone for insertion of the lipid tails in their respective pockets. The 3 ' sulfated galactose headgroup is highly exposed for presentation to the T cell receptor and projects up and away from the binding pocket due to its beta linkage, compared with the more intimate binding of the alpha - glactosyl ceramide headgroup to CD1d. These structure and binding data on sulfatide presentation by CD1d have important implications for the design of therapeutics that target T cells reactive for myelin glycolipids in autoimmune diseases of the central nervous system.
引用
收藏
页码:1517 / 1526
页数:10
相关论文
共 54 条
[1]  
Acarin N, 1996, ACTA NEUROL SCAND, V93, P99
[2]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[3]   IGM GANGLIOSIDE GM1 ANTIBODIES IN PATIENTS WITH AUTOIMMUNE-DISEASE OR NEUROPATHY, AND CONTROLS [J].
BANSAL, AS ;
ABDULKARIM, B ;
MALIK, RA ;
GOULDING, P ;
PUMPHREY, RSH ;
BOULTON, AJM ;
HOLT, PLJ ;
WILSON, PB .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (04) :300-302
[4]  
Battistini L, 1996, J NEUROIMMUNOL, V67, P145
[5]   The crystal structure of human CD1b with a bound bacterial glycolipid [J].
Batuwangala, T ;
Shepherd, D ;
Gadola, SD ;
Gibson, KJC ;
Zaccai, NR ;
Fersht, AR ;
Besra, GS ;
Cerundolo, V ;
Jones, EY .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2382-2388
[6]   MOUSE NK1(+) T-CELLS [J].
BENDELAC, A .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (03) :367-374
[7]   CD1: Antigen presentation and T cell function [J].
Brigl, M ;
Brenner, MB .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :817-890
[8]   FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES [J].
BRUNGER, AT .
NATURE, 1992, 355 (6359) :472-475
[9]   CD1a-binding glycosphingolipids stimulating human autoreactive T-cells: synthesis of a family of sulfatides differing in the acyl chain moiety [J].
Compostella, F ;
Franchini, L ;
De Libero, G ;
Palmisano, G ;
Ronchetti, F ;
Panza, L .
TETRAHEDRON, 2002, 58 (43) :8703-8708
[10]   Recognition of lipid antigens by T cells [J].
De Libero, G ;
Mori, L .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (06) :485-496